摘要 |
The present invention provides novel markers of the severity of a central nervous system injury, such as spinal cord injury or traumatic brain injury, in a patient. In particular, protein components of inflammasomes in the cerebrospinal fluid that can be used to assess the severity of central nervous system injury in a patient are disclosed. Methods of using such protein biomarkers to determine a prognosis, direct treatment and rehabilitation efforts, and monitor response to treatment for a patient with a central nervous system injury are also described. |
申请人 |
UNIVERSITY OF MIAMI |
发明人 |
KEANE, ROBERT, W.;DIETRICH, W., DALTON;VACCARI, JUAN, PABLO DE RIVERO;ADAMCZAK, STEPHANIE;BULLOCK, M., ROSS;LEVI, ALLAN;WANG, MICHAEL, Y. |